RopesTalk

In this engaging discussion, Tal Freilich, Vice President of Group Governance, Risk and Compliance at DKSH, shares his expertise in navigating compliance across culturally diverse markets. He emphasizes the role of cultural understanding in shaping effective compliance initiatives and the importance of tailored frameworks to foster trust. Tal also highlights how AI and data analytics can enhance compliance programs while balancing technology with human insight. Embracing failure as a learning tool and evolving compliance from mere support to an enabler are key takeaways that inspire thoughtful strategies in any organization.

On this episode of Ropes & Gray’s podcast series Controlling Opinions, life sciences regulatory and compliance partner Josh Oyster and counsel Beth Weinman are joined by health care partner Brett Friedman and litigation and enforcement partner Andrew O’Connor to discuss what’s to come in 2025 under the new Trump administration on key issues relating to controlled substances. The discussion covers: The DEA’s potential rescheduling of cannabis and the ongoing administrative hearing process.Updates on telemedicine flexibilities for prescribing controlled substances, including new rules and proposed regulations.Latest enforcement developments from the DOJ related to controlled substance prescribing via telemedicine, including notable cases and implications for the future.Tune in for an insightful conversation on these critical topics and stay informed about the latest legal and regulatory changes in the life sciences and health care industries. 

On this episode of the R&G Dugout podcast, Ropes & Gray asset management partners Amanda Persaud, Lindsey Goldstein, and Jon Rash explore the upsurge of private funds raising capital for investment in sports teams and businesses. They discuss the various structures of sports funds, the challenges of valuing sports assets, and the unique considerations for investing in U.S. sports leagues and teams. Tune in to understand how private capital is navigating this dynamic industry and the innovative fund structures emerging in response.

In this insightful conversation, Letitia Adu-Ampoma, an accomplished compliance professional with 15 years of experience, shares her expertise in aligning global compliance with local cultures. She highlights the importance of understanding cultural nuances to enhance program effectiveness. Letitia discusses how demographics, technology, and local values shape compliance outcomes. With real-world examples, she emphasizes tailoring training and policies to resonate with specific cultural contexts, particularly in industries like pharmaceuticals, to promote better ethical practices globally.

On this episode of Ropes & Gray’s Antitrust Insights podcast series, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino (“HSR”) Act rules, which go into effect on February 10, 2025, and the challenges faced by pharmaceutical clients and the strategic adjustments required for compliance. Tune in to understand how these changes will affect acquisitions, licensing and collaboration transactions and other strategic transactions, as well as the overall regulatory landscape. 

Welcome to the R&G Dugout, a new Ropes & Gray podcast series that delves into the dynamic world of sports investing, with a particular focus on the evolving ecosystem of media, entertainment, and private capital ventures. On this inaugural episode, Ropes & Gray partners Amanda Persaud, Patrick Dorime, and Erica Han discuss the transformative changes occurring in the sports industry, from the recent updates in ownership rules in professional leagues to the burgeoning interest in college athletics and private capital investments. This episode provides a foundational background in the sports investment landscape, addressing key questions about structuring investments, navigating regulatory complexities, and leveraging cross-disciplinary legal experience. Tune in to learn how Ropes & Gray and industry insiders are shaping the future of sports transactions. 

Danny Mayhew, Global Head of Organisational Justice at Sanofi, brings a wealth of experience from law enforcement to corporate compliance. He discusses the crucial role of empathy in investigations and how fostering organizational justice can enhance workplace fairness. The conversation delves into leveraging AI and machine learning for predictive compliance, promoting transparency through data insights, and the establishment of an internal ombuds office for conflict resolution. Danny emphasizes the need for a supportive culture and proactive measures to prevent misconduct.

On this episode of Ropes & Gray’s podcast series A Word for Our Sponsors, Deb Lussier, partner and co-leader of the sponsor solutions practice, and Marc Migliazzo, counsel in the sponsor solutions practice, are joined by Darren O’Brien and Chirag Shah, managing directors on the secondary advisory team for Campbell Lutyens. Together, they examine the results of a “North America Private Equity GP-Led Secondary Perceptions” survey they jointly conducted this year, and explore the booming GP-led secondaries market, discussing key trends, the importance of LP-GP alignment, and the strategic use of continuation funds. Tune in to gain valuable insights on how these transactions are shaping the future of private equity. 

Join us for the final episode of our Health Care Transaction Laws Unwrapped podcast series, where Ropes & Gray antitrust partner Jane Willis and counsel David Young explore the intersection of health care transaction laws and antitrust enforcement. They discuss major trends influencing health care transactions, the impact of political changes on antitrust enforcement, and specific issues such as community hospital acquisitions, system-to-system mergers, and private equity investments in health care. The episode provides insights into how these factors shape the regulatory landscape and what health care providers and investors can expect moving forward.

On this episode of Ropes & Gray’s podcast series Non-binding Guidance, health care partner David Peloquin and life sciences regulatory and compliance counsel Sarah Blankstein discuss the FDA's recent draft guidance on diversity action plans (DAPs) aimed at improving the enrollment of underrepresented populations in clinical studies. They examine the implications and challenges sponsors may face in setting and meeting enrollment goals, as well as the potential impact of the recent presidential election on the final guidance. They also address key open questions related to the draft guidance.